Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,639
Total Claims
$1.9M
Drug Cost
936
Beneficiaries
$2,019
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-96%
Opioid rate vs peers
0.1% vs 2.2% avg
+43%
Cost per patient vs peers
$2,019 vs $1,411 avg
+72%
Brand preference vs peers
18.2% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
17
Opioid Claims
$295
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,754 claims · $1.4M
Generic: 16,834 claims · $531K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 896 | $262K |
| Valbenazine Tosylate | 49 | $179K |
| Dulaglutide | 234 | $164K |
| Rivaroxaban | 237 | $67K |
| Fluticasone/Umeclidin/Vilanter | 57 | $33K |
| Insulin Glargine,hum.Rec.Anlog | 104 | $32K |
| Insulin Glargine,hum.Rec.Anlog | 174 | $29K |
| Fluticasone/Vilanterol | 81 | $24K |
| Dimethyl Fumarate | 21 | $24K |
| Insulin Lispro | 77 | $22K |
| Sitagliptin Phosphate | 76 | $21K |
| Linaclotide | 34 | $19K |
| Divalproex Sodium | 298 | $19K |
| Budesonide/Formoterol Fumarate | 45 | $18K |
| Empagliflozin | 59 | $18K |
Prescribing Profile
Patient Profile
77
Avg Age
61%
Female
2.80
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About